Menu Back toSpotlight Symposia: Managing Stakeholders in the Decentralized and Hybrid Clinical Trial Ecosystem

DIA 2021 Global Annual Meeting


Spotlight Symposia: Managing Stakeholders in the Decentralized and Hybrid Clinical Trial Ecosystem

Session Chair(s)

  ICON plc

ICON plc

  • United States
Decentralized and hybrid clinical trials involve more than apps and digital tools. As the industry evolves from the traditional site-based research model to more decentralized study conduct, we must be mindful of the impact of pushing burden downstream to investigators and patients. We will share patient and site perspectives related to decentralization and explore operationalizing these studies considering the impact on regulatory, quality, supply management, and data harmonization.

Speaker(s)

E.B.  McLindon

E.B. McLindon

  • Senior Vice President, Patient, Site & Decentralized Solutions
  • ICON plc, United States
Isaac R Rodriguez-Chavez, MHS, PhD, MS

Isaac R Rodriguez-Chavez, MHS, PhD, MS

  • Senior Vice President, Scientific and Clinical Affairs, Head, Global COE
  • ICON plc, United States